Medtronic Appoints Cleveland Clinic Surgeon Dr. Matthew Kroh as Chief Medical Officer for Advanced and General Surgical Technologies

Oct 29, 2024 18:01 CST Updated 18:02

Medtronic

Medical Device Manufacturer

Instrument Family

Medical Device Media Reporting Pioneer

Share Professional Medical Device Knowledge

Source: Instrument Family

On October 28, 2024, Medtronic announced,Appointment of Dr. Matthew Kroh as Chief Medical Officer for Advanced and General Surgical Technologies.Dr. Matthew Kroh is the Vice Chairman of Innovation and Technology at the Cleveland Clinic's Digestive Disease and Surgery Institute. He is also the Director of Endoscopic Surgery and Foregut Surgery within the General Surgery department.

Laparoscopic Surgery Specialist at Cleveland Clinic

Cleveland Clinic is one of the most renowned medical institutions in the world, established on February 28, 1921. In the 2017-2018 ranking of the best hospitals in the United States,Cleveland Clinic ranks second in the comprehensive ranking across the United States, just behind Mayo Clinic. Its departments of cardiac surgery and urology rank first in the U.S., while general surgery, rheumatology, and nephrology rank second. Dr. Matthew Kroh is from Cleveland Clinic.

According to the official website of the Cleveland Clinic, Dr. Matthew Kroh is the Vice Chair of Innovation and Technology at the Cleveland Clinic's Digestive Disease and Surgery Institute.He is the director of endoscopic surgery and foregut surgery in the Department of General Surgery. Dr. Kroh also holds positions at the Bariatric and Metabolic Institute and the Center for Surgical Innovation, Technology, and Education, located on the main campus of the Cleveland Clinic. He is a professor of surgery at the Cleveland Clinic Lerner College of Medicine. He is licensed by the Ohio State Medical Board and certified by the American Board of Surgery. His areas of expertise include advanced laparoscopic surgery, bariatric surgery, gastrointestinal surgery, surgical endoscopy, single-incision laparoscopic surgery, and robotic surgery.

After earning a bachelor's degree in biology from Boston College and a master's degree from Boston University, Dr. Clough obtained his medical degree from the Icahn School of Medicine at Mount Sinai, New York University.

Dr. Cro has delivered extensive speeches on laparoscopic and bariatric surgery and related topics at medical conferences across China and around the world. He has also co-authored numerous articles and book chapters that have appeared in leading medical journals, such as the Journal of the American College of Surgeons and Surgical Endoscopy.He has participated in numerous research projects in this field, including fluoroscopy as an auxiliary method for laparoscopic gastric band adjustment in morbidly obese patients, predictive factors of advanced liver disease in patients undergoing bariatric surgery, the development of new devices for endoscopic management of Barrett's esophagus, and new approaches to minimally invasive laparoscopic surgery, including robotic technology, single-incision laparoscopic surgery, NOTES, POEM, and ESD procedures.

He is a member of the American College of Surgeons, the American Surgical Association, the American Society for Metabolic and Bariatric Surgery, the Society of American Gastrointestinal and Endoscopic Surgeons, the Association for Surgical Education, the American College of Gastroenterology, and the Central Surgical Association.

Cro is a board-certified surgeon with extensive experience in advanced laparoscopic and bariatric surgery as well as surgical endoscopy. On the official website of Cleveland Clinic, 108 patients gave him an average rating of 4.8 out of 5. Multiple patients acknowledged him as an excellent doctor.

In his new role, Cro plans to continue performing surgeries at the Cleveland Clinic.

"I am honored to join Medtronic, a company renowned for leading healthcare transformation through innovation," said Kehl. "I look forward to contributing to the development of surgical technologies that can make treatments more accessible to patients worldwide and improve their outcomes."

Regarding the appointment of Cro, Medtronic stated that he possesses extensive clinical and healthcare leadership experience, which will guide the development and commercialization strategies of new products. Under his leadership, the company aims to deepen clinical insights and strengthen collaboration with doctors and medical associations. The appointment of Cro highlights Medtronic's commitment to advancing surgical innovation and improving patient outcomes.

"We are thrilled to have Dr. Kroll join Medtronic, bringing his expertise, passion, and innovative spirit to our business," said Justin Roberts, General Manager and Vice President of Advanced Surgical Technologies at Medtronic's Surgical Business. "His pioneering experience in the field of surgical innovation will be invaluable as we continue to push the boundaries of medical technology."

Medtronic Invests in Surgery, Appoints Expert as Chief Medical Officer

The change in senior management indicates that Medtronic is gradually increasing its focus on the surgical sector.

In September this year, Medtronic officially appointed Dr. James Porter, a urology expert, as the Chief Medical Officer (CMO) for robotic and digital technologies in its surgical business. Dr. Porter has extensive experience with over 5,000 robot-assisted surgeries in the field of urology and is acclaimed as a "recognized leader" in the global surgical community. Additionally, he is one of the top robotic surgery experts in the U.S., ranking among the top five nationwide. Dr. Porter previously served as the Director of Urology at Harborview Medical Center and later headed the laparoscopic and robotic surgery department in the urology department at the University of Washington Medical Center.

This business is part of the medical surgical product portfolio — on February 1, 2023, Medtronic announced the merger of its surgical robotics and surgical innovation business units into a single surgical business unit.The main core of the new business department is Medtronic's robot-assisted surgery system, Hugo.

Dr. James Porter

Medtronic stated that Dr. Porter’s addition brings extensive clinical experience to the company, which can help further enhance its robotics and digital technology business. His responsibilities include overseeing the strategic direction of clinical evidence programs and fostering in-depth collaboration with physicians and the broader community. Additionally, he will continue to perform surgeries part-time at Providence Swedish Hospital in Seattle.

Regarding this appointment, Porter said: "My original intention of entering the medical field was to help patients. Now, being able to expand this impact globally through Medtronic excites me greatly. There are still tens of millions of patients worldwide who lack access to minimally invasive surgical treatments. I look forward to collaborating with the Medtronic team to advance the development of medical technology."

In recent years, Medtronic has been making continuous efforts in the field of robotic surgery. The Hugo Robotic-Assisted Surgery System, launched by the company, has become its representative product in the surgical robotics sector and is considered by many to be Intuitive Surgical's "most dangerous" competitor, with the potential to become the next da Vinci system. The development and collaboration of laparoscopes and surgical robots are mutually reinforcing. Therefore, what kind of support will the arrival of these two Chief Medical Officers bring to Medtronic's surgical division? And what strategies does Medtronic have in the field of minimally invasive surgery? Instrument Family will continue to follow up.

END

United Imaging First, Top Rankings of County DR Market in Recent Three Years

GE Healthcare, this product was manufactured in the U.S. for the first time

1.45 Billion: The Layout of "China's Leading Core Component of Imaging"

"How to Develop During the 'Reverse Globalization' Period? Responses from Medtronic, GE Healthcare, and Philips"

Mayo Clinic: Layoffs, Restructuring

French President Praises: New Breakthrough in 11.7T MRI

Medtronic: Major Collaboration Reached with Philips

Philips Greater China, Major Executive Changes

774 Million, Mindray Makes a Big Move

Mass Layoffs Begin? Where is SenseTime's Medical Path Heading?

BusinessBusiness cooperation email: qxzj@landianyiliao.com